脑膜中动脉栓塞治疗慢性硬脑膜下血肿的有效性和安全性分析  

Analysis of the Effectiveness and Safety of Middle Meningeal Artery Embolization in the Treatment of Chronic Subdural Hematoma

作　　者：张君 Zhang Jun(Nanjing Jiangning Hospital of Traditional Chinese Medicine,Nanjing 210000,Jiangsu Province,China)

机构地区：[1]南京市江宁中医院,江苏南京210000

出　　处：《中外医药研究》2024年第11期42-44,共3页JOURNAL OF CHINESE AND FOREIGN MEDICINE AND PHARMACY RESEARCH

摘　　要：目的:分析脑膜中动脉(MMA)栓塞治疗慢性硬脑膜下血肿(CSDH)的有效性和安全性。方法:选取2021年1月—2023年12月南京市江宁中医院收治的CSDH患者100例为研究对象,以随机数字表法分为参照组和试验组,各50例。两组均接受保守治疗,在此基础上,参照组采用外科钻孔引流术治疗,试验组采用MMA栓塞治疗。比较两组功能障碍程度、生活质量、血肿吸收效果、血肿复发率及并发症发生率。结果:治疗后,两组改良Rankin量表评分降低,生活质量评定量表评分升高,试验组改良Rankin量表评分低于参照组,生活质量评定量表评分高于参照组,差异有统计学意义(P<0.05)。试验组吸收率高于参照组,差异有统计学意义(P<0.001);试验组血肿复发率低于参照组,差异有统计学意义(P=0.041);试验组并发症发生率低于参照组,差异有统计学意义(P=0.027)。结论:MMA栓塞治疗CSDH的临床效果较好,可改善患者功能障碍程度,提高生活质量,促进血肿吸收,预防血肿复发,减少并发症。Objective:To analyze the effectiveness and safety of middle meningeal artery(MMA)embolization for chronic subdural hematoma(CSDH).Methods:One hundred patients with CSDH admitted to Nanjing Jiangning Hospital of Traditional Chinese Medicine from January 2021 to December 2023 were selected as the study subjects,and were divided into the reference group and the experimental group by using the randomized numerical table method,each with fifty cases.Both groups received conservative treatment.On this basis,the reference group was treated with surgical drilling and drainage,and the experimental group was treated with MMA embolization.The degree of functional disability,quality of life,hematoma absorption effect,hematoma recurrence rate and complication rate were compared between the two groups.Results:After treatment,the Modified Rankin Scale score decreased and the Quality of Life Scale score increased in both groups;the Modified Rankin Scale score in the experimental group was lower than that of the reference group,and the Quality of Life Scale score was higher than that of the reference group,with a statistically significant difference(P<0.05);the absorption rate of the experimental group was higher than that of the reference group,with a statistically significant difference(P<0.001);the hematoma recurrence rate of the experimental group was lower than that of the reference group,and the difference was statistically significant(P=0.041);the complication rate of the experimental group was lower than that of the reference group,and the difference was statistically significant(P=0.027).Conclusion:The clinical effect of MMA embolization for CSDH is better,which can improve the degree of dysfunction of patients,improve the quality of life,promote the absorption of hematoma,prevent the recurrence of hematoma,and reduce the complications.

关 键 词：慢性硬脑膜下血肿 脑膜中动脉栓塞 钻孔引流术 

分 类 号：R651.12[医药卫生—外科学]